Global PD-1 and PD-L1 Monoclonal Antibody Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global PD-1 and PD-L1 Monoclonal Antibody market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global PD-1 and PD-L1 Monoclonal Antibody Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the PD-1 and PD-L1 Monoclonal Antibody market in any manner.
Global PD-1 and PD-L1 Monoclonal Antibody Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merk
Bristol-Myers Squibb Company
Roche
Pfizer
AstraZeneca
Junshi Biosciences
Innovent
Hengrui
BeiGene
Alphamab Oncology
Cstone
Akeso
Market Segmentation (by Type)
PD-1
PD-L1
Market Segmentation (by Application)
Lung Cancer
Liver Cancer
Esophageal Cancer
Gastric Cancer
Nasopharyngeal Carcinoma
Head and Neck Cancer
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the PD-1 and PD-L1 Monoclonal Antibody Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global PD-1 and PD-L1 Monoclonal Antibody market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global PD-1 and PD-L1 Monoclonal Antibody Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the PD-1 and PD-L1 Monoclonal Antibody market in any manner.
Global PD-1 and PD-L1 Monoclonal Antibody Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merk
Bristol-Myers Squibb Company
Roche
Pfizer
AstraZeneca
Junshi Biosciences
Innovent
Hengrui
BeiGene
Alphamab Oncology
Cstone
Akeso
Market Segmentation (by Type)
PD-1
PD-L1
Market Segmentation (by Application)
Lung Cancer
Liver Cancer
Esophageal Cancer
Gastric Cancer
Nasopharyngeal Carcinoma
Head and Neck Cancer
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the PD-1 and PD-L1 Monoclonal Antibody Market
- Overview of the regional outlook of the PD-1 and PD-L1 Monoclonal Antibody Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the PD-1 and PD-L1 Monoclonal Antibody Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of PD-1 and PD-L1 Monoclonal Antibody
1.2 Key Market Segments
1.2.1 PD-1 and PD-L1 Monoclonal Antibody Segment by Type
1.2.2 PD-1 and PD-L1 Monoclonal Antibody Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PD-1 AND PD-L1 MONOCLONAL ANTIBODY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global PD-1 and PD-L1 Monoclonal Antibody Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global PD-1 and PD-L1 Monoclonal Antibody Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PD-1 AND PD-L1 MONOCLONAL ANTIBODY MARKET COMPETITIVE LANDSCAPE
3.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales by Manufacturers (2019-2024)
3.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Manufacturers (2019-2024)
3.3 PD-1 and PD-L1 Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Manufacturers (2019-2024)
3.5 Manufacturers PD-1 and PD-L1 Monoclonal Antibody Sales Sites, Area Served, Product Type
3.6 PD-1 and PD-L1 Monoclonal Antibody Market Competitive Situation and Trends
3.6.1 PD-1 and PD-L1 Monoclonal Antibody Market Concentration Rate
3.6.2 Global 5 and 10 Largest PD-1 and PD-L1 Monoclonal Antibody Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PD-1 AND PD-L1 MONOCLONAL ANTIBODY INDUSTRY CHAIN ANALYSIS
4.1 PD-1 and PD-L1 Monoclonal Antibody Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PD-1 AND PD-L1 MONOCLONAL ANTIBODY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PD-1 AND PD-L1 MONOCLONAL ANTIBODY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type (2019-2024)
6.3 Global PD-1 and PD-L1 Monoclonal Antibody Market Size Market Share by Type (2019-2024)
6.4 Global PD-1 and PD-L1 Monoclonal Antibody Price by Type (2019-2024)
7 PD-1 AND PD-L1 MONOCLONAL ANTIBODY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global PD-1 and PD-L1 Monoclonal Antibody Market Sales by Application (2019-2024)
7.3 Global PD-1 and PD-L1 Monoclonal Antibody Market Size (M USD) by Application (2019-2024)
7.4 Global PD-1 and PD-L1 Monoclonal Antibody Sales Growth Rate by Application (2019-2024)
8 PD-1 AND PD-L1 MONOCLONAL ANTIBODY MARKET SEGMENTATION BY REGION
8.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales by Region
8.1.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales by Region
8.1.2 Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region
8.2 North America
8.2.1 North America PD-1 and PD-L1 Monoclonal Antibody Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America PD-1 and PD-L1 Monoclonal Antibody Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Merk
9.1.1 Merk PD-1 and PD-L1 Monoclonal Antibody Basic Information
9.1.2 Merk PD-1 and PD-L1 Monoclonal Antibody Product Overview
9.1.3 Merk PD-1 and PD-L1 Monoclonal Antibody Product Market Performance
9.1.4 Merk Business Overview
9.1.5 Merk PD-1 and PD-L1 Monoclonal Antibody SWOT Analysis
9.1.6 Merk Recent Developments
9.2 Bristol-Myers Squibb Company
9.2.1 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Basic Information
9.2.2 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Product Overview
9.2.3 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Product Market Performance
9.2.4 Bristol-Myers Squibb Company Business Overview
9.2.5 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody SWOT Analysis
9.2.6 Bristol-Myers Squibb Company Recent Developments
9.3 Roche
9.3.1 Roche PD-1 and PD-L1 Monoclonal Antibody Basic Information
9.3.2 Roche PD-1 and PD-L1 Monoclonal Antibody Product Overview
9.3.3 Roche PD-1 and PD-L1 Monoclonal Antibody Product Market Performance
9.3.4 Roche PD-1 and PD-L1 Monoclonal Antibody SWOT Analysis
9.3.5 Roche Business Overview
9.3.6 Roche Recent Developments
9.4 Pfizer
9.4.1 Pfizer PD-1 and PD-L1 Monoclonal Antibody Basic Information
9.4.2 Pfizer PD-1 and PD-L1 Monoclonal Antibody Product Overview
9.4.3 Pfizer PD-1 and PD-L1 Monoclonal Antibody Product Market Performance
9.4.4 Pfizer Business Overview
9.4.5 Pfizer Recent Developments
9.5 AstraZeneca
9.5.1 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Basic Information
9.5.2 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Product Overview
9.5.3 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Product Market Performance
9.5.4 AstraZeneca Business Overview
9.5.5 AstraZeneca Recent Developments
9.6 Junshi Biosciences
9.6.1 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Basic Information
9.6.2 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Product Overview
9.6.3 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Product Market Performance
9.6.4 Junshi Biosciences Business Overview
9.6.5 Junshi Biosciences Recent Developments
9.7 Innovent
9.7.1 Innovent PD-1 and PD-L1 Monoclonal Antibody Basic Information
9.7.2 Innovent PD-1 and PD-L1 Monoclonal Antibody Product Overview
9.7.3 Innovent PD-1 and PD-L1 Monoclonal Antibody Product Market Performance
9.7.4 Innovent Business Overview
9.7.5 Innovent Recent Developments
9.8 Hengrui
9.8.1 Hengrui PD-1 and PD-L1 Monoclonal Antibody Basic Information
9.8.2 Hengrui PD-1 and PD-L1 Monoclonal Antibody Product Overview
9.8.3 Hengrui PD-1 and PD-L1 Monoclonal Antibody Product Market Performance
9.8.4 Hengrui Business Overview
9.8.5 Hengrui Recent Developments
9.9 BeiGene
9.9.1 BeiGene PD-1 and PD-L1 Monoclonal Antibody Basic Information
9.9.2 BeiGene PD-1 and PD-L1 Monoclonal Antibody Product Overview
9.9.3 BeiGene PD-1 and PD-L1 Monoclonal Antibody Product Market Performance
9.9.4 BeiGene Business Overview
9.9.5 BeiGene Recent Developments
9.10 Alphamab Oncology
9.10.1 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Basic Information
9.10.2 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Product Overview
9.10.3 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Product Market Performance
9.10.4 Alphamab Oncology Business Overview
9.10.5 Alphamab Oncology Recent Developments
9.11 Cstone
9.11.1 Cstone PD-1 and PD-L1 Monoclonal Antibody Basic Information
9.11.2 Cstone PD-1 and PD-L1 Monoclonal Antibody Product Overview
9.11.3 Cstone PD-1 and PD-L1 Monoclonal Antibody Product Market Performance
9.11.4 Cstone Business Overview
9.11.5 Cstone Recent Developments
9.12 Akeso
9.12.1 Akeso PD-1 and PD-L1 Monoclonal Antibody Basic Information
9.12.2 Akeso PD-1 and PD-L1 Monoclonal Antibody Product Overview
9.12.3 Akeso PD-1 and PD-L1 Monoclonal Antibody Product Market Performance
9.12.4 Akeso Business Overview
9.12.5 Akeso Recent Developments
10 PD-1 AND PD-L1 MONOCLONAL ANTIBODY MARKET FORECAST BY REGION
10.1 Global PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast
10.2 Global PD-1 and PD-L1 Monoclonal Antibody Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast by Country
10.2.3 Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast by Region
10.2.4 South America PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of PD-1 and PD-L1 Monoclonal Antibody by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global PD-1 and PD-L1 Monoclonal Antibody Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of PD-1 and PD-L1 Monoclonal Antibody by Type (2025-2030)
11.1.2 Global PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of PD-1 and PD-L1 Monoclonal Antibody by Type (2025-2030)
11.2 Global PD-1 and PD-L1 Monoclonal Antibody Market Forecast by Application (2025-2030)
11.2.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons) Forecast by Application
11.2.2 Global PD-1 and PD-L1 Monoclonal Antibody Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of PD-1 and PD-L1 Monoclonal Antibody
1.2 Key Market Segments
1.2.1 PD-1 and PD-L1 Monoclonal Antibody Segment by Type
1.2.2 PD-1 and PD-L1 Monoclonal Antibody Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PD-1 AND PD-L1 MONOCLONAL ANTIBODY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global PD-1 and PD-L1 Monoclonal Antibody Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global PD-1 and PD-L1 Monoclonal Antibody Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PD-1 AND PD-L1 MONOCLONAL ANTIBODY MARKET COMPETITIVE LANDSCAPE
3.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales by Manufacturers (2019-2024)
3.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Manufacturers (2019-2024)
3.3 PD-1 and PD-L1 Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Manufacturers (2019-2024)
3.5 Manufacturers PD-1 and PD-L1 Monoclonal Antibody Sales Sites, Area Served, Product Type
3.6 PD-1 and PD-L1 Monoclonal Antibody Market Competitive Situation and Trends
3.6.1 PD-1 and PD-L1 Monoclonal Antibody Market Concentration Rate
3.6.2 Global 5 and 10 Largest PD-1 and PD-L1 Monoclonal Antibody Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PD-1 AND PD-L1 MONOCLONAL ANTIBODY INDUSTRY CHAIN ANALYSIS
4.1 PD-1 and PD-L1 Monoclonal Antibody Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PD-1 AND PD-L1 MONOCLONAL ANTIBODY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PD-1 AND PD-L1 MONOCLONAL ANTIBODY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type (2019-2024)
6.3 Global PD-1 and PD-L1 Monoclonal Antibody Market Size Market Share by Type (2019-2024)
6.4 Global PD-1 and PD-L1 Monoclonal Antibody Price by Type (2019-2024)
7 PD-1 AND PD-L1 MONOCLONAL ANTIBODY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global PD-1 and PD-L1 Monoclonal Antibody Market Sales by Application (2019-2024)
7.3 Global PD-1 and PD-L1 Monoclonal Antibody Market Size (M USD) by Application (2019-2024)
7.4 Global PD-1 and PD-L1 Monoclonal Antibody Sales Growth Rate by Application (2019-2024)
8 PD-1 AND PD-L1 MONOCLONAL ANTIBODY MARKET SEGMENTATION BY REGION
8.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales by Region
8.1.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales by Region
8.1.2 Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region
8.2 North America
8.2.1 North America PD-1 and PD-L1 Monoclonal Antibody Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America PD-1 and PD-L1 Monoclonal Antibody Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Merk
9.1.1 Merk PD-1 and PD-L1 Monoclonal Antibody Basic Information
9.1.2 Merk PD-1 and PD-L1 Monoclonal Antibody Product Overview
9.1.3 Merk PD-1 and PD-L1 Monoclonal Antibody Product Market Performance
9.1.4 Merk Business Overview
9.1.5 Merk PD-1 and PD-L1 Monoclonal Antibody SWOT Analysis
9.1.6 Merk Recent Developments
9.2 Bristol-Myers Squibb Company
9.2.1 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Basic Information
9.2.2 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Product Overview
9.2.3 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Product Market Performance
9.2.4 Bristol-Myers Squibb Company Business Overview
9.2.5 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody SWOT Analysis
9.2.6 Bristol-Myers Squibb Company Recent Developments
9.3 Roche
9.3.1 Roche PD-1 and PD-L1 Monoclonal Antibody Basic Information
9.3.2 Roche PD-1 and PD-L1 Monoclonal Antibody Product Overview
9.3.3 Roche PD-1 and PD-L1 Monoclonal Antibody Product Market Performance
9.3.4 Roche PD-1 and PD-L1 Monoclonal Antibody SWOT Analysis
9.3.5 Roche Business Overview
9.3.6 Roche Recent Developments
9.4 Pfizer
9.4.1 Pfizer PD-1 and PD-L1 Monoclonal Antibody Basic Information
9.4.2 Pfizer PD-1 and PD-L1 Monoclonal Antibody Product Overview
9.4.3 Pfizer PD-1 and PD-L1 Monoclonal Antibody Product Market Performance
9.4.4 Pfizer Business Overview
9.4.5 Pfizer Recent Developments
9.5 AstraZeneca
9.5.1 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Basic Information
9.5.2 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Product Overview
9.5.3 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Product Market Performance
9.5.4 AstraZeneca Business Overview
9.5.5 AstraZeneca Recent Developments
9.6 Junshi Biosciences
9.6.1 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Basic Information
9.6.2 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Product Overview
9.6.3 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Product Market Performance
9.6.4 Junshi Biosciences Business Overview
9.6.5 Junshi Biosciences Recent Developments
9.7 Innovent
9.7.1 Innovent PD-1 and PD-L1 Monoclonal Antibody Basic Information
9.7.2 Innovent PD-1 and PD-L1 Monoclonal Antibody Product Overview
9.7.3 Innovent PD-1 and PD-L1 Monoclonal Antibody Product Market Performance
9.7.4 Innovent Business Overview
9.7.5 Innovent Recent Developments
9.8 Hengrui
9.8.1 Hengrui PD-1 and PD-L1 Monoclonal Antibody Basic Information
9.8.2 Hengrui PD-1 and PD-L1 Monoclonal Antibody Product Overview
9.8.3 Hengrui PD-1 and PD-L1 Monoclonal Antibody Product Market Performance
9.8.4 Hengrui Business Overview
9.8.5 Hengrui Recent Developments
9.9 BeiGene
9.9.1 BeiGene PD-1 and PD-L1 Monoclonal Antibody Basic Information
9.9.2 BeiGene PD-1 and PD-L1 Monoclonal Antibody Product Overview
9.9.3 BeiGene PD-1 and PD-L1 Monoclonal Antibody Product Market Performance
9.9.4 BeiGene Business Overview
9.9.5 BeiGene Recent Developments
9.10 Alphamab Oncology
9.10.1 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Basic Information
9.10.2 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Product Overview
9.10.3 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Product Market Performance
9.10.4 Alphamab Oncology Business Overview
9.10.5 Alphamab Oncology Recent Developments
9.11 Cstone
9.11.1 Cstone PD-1 and PD-L1 Monoclonal Antibody Basic Information
9.11.2 Cstone PD-1 and PD-L1 Monoclonal Antibody Product Overview
9.11.3 Cstone PD-1 and PD-L1 Monoclonal Antibody Product Market Performance
9.11.4 Cstone Business Overview
9.11.5 Cstone Recent Developments
9.12 Akeso
9.12.1 Akeso PD-1 and PD-L1 Monoclonal Antibody Basic Information
9.12.2 Akeso PD-1 and PD-L1 Monoclonal Antibody Product Overview
9.12.3 Akeso PD-1 and PD-L1 Monoclonal Antibody Product Market Performance
9.12.4 Akeso Business Overview
9.12.5 Akeso Recent Developments
10 PD-1 AND PD-L1 MONOCLONAL ANTIBODY MARKET FORECAST BY REGION
10.1 Global PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast
10.2 Global PD-1 and PD-L1 Monoclonal Antibody Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast by Country
10.2.3 Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast by Region
10.2.4 South America PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of PD-1 and PD-L1 Monoclonal Antibody by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global PD-1 and PD-L1 Monoclonal Antibody Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of PD-1 and PD-L1 Monoclonal Antibody by Type (2025-2030)
11.1.2 Global PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of PD-1 and PD-L1 Monoclonal Antibody by Type (2025-2030)
11.2 Global PD-1 and PD-L1 Monoclonal Antibody Market Forecast by Application (2025-2030)
11.2.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons) Forecast by Application
11.2.2 Global PD-1 and PD-L1 Monoclonal Antibody Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. PD-1 and PD-L1 Monoclonal Antibody Market Size Comparison by Region (M USD)
Table 5. Global PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Manufacturers (2019-2024)
Table 7. Global PD-1 and PD-L1 Monoclonal Antibody Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1 and PD-L1 Monoclonal Antibody as of 2022)
Table 10. Global Market PD-1 and PD-L1 Monoclonal Antibody Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers PD-1 and PD-L1 Monoclonal Antibody Sales Sites and Area Served
Table 12. Manufacturers PD-1 and PD-L1 Monoclonal Antibody Product Type
Table 13. Global PD-1 and PD-L1 Monoclonal Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of PD-1 and PD-L1 Monoclonal Antibody
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. PD-1 and PD-L1 Monoclonal Antibody Market Challenges
Table 22. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Type (Kilotons)
Table 23. Global PD-1 and PD-L1 Monoclonal Antibody Market Size by Type (M USD)
Table 24. Global PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons) by Type (2019-2024)
Table 25. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type (2019-2024)
Table 26. Global PD-1 and PD-L1 Monoclonal Antibody Market Size (M USD) by Type (2019-2024)
Table 27. Global PD-1 and PD-L1 Monoclonal Antibody Market Size Share by Type (2019-2024)
Table 28. Global PD-1 and PD-L1 Monoclonal Antibody Price (USD/Ton) by Type (2019-2024)
Table 29. Global PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons) by Application
Table 30. Global PD-1 and PD-L1 Monoclonal Antibody Market Size by Application
Table 31. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2019-2024) & (Kilotons)
Table 32. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2019-2024)
Table 33. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2019-2024) & (M USD)
Table 34. Global PD-1 and PD-L1 Monoclonal Antibody Market Share by Application (2019-2024)
Table 35. Global PD-1 and PD-L1 Monoclonal Antibody Sales Growth Rate by Application (2019-2024)
Table 36. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2019-2024) & (Kilotons)
Table 37. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region (2019-2024)
Table 38. North America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2019-2024) & (Kilotons)
Table 41. South America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2019-2024) & (Kilotons)
Table 43. Merk PD-1 and PD-L1 Monoclonal Antibody Basic Information
Table 44. Merk PD-1 and PD-L1 Monoclonal Antibody Product Overview
Table 45. Merk PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Merk Business Overview
Table 47. Merk PD-1 and PD-L1 Monoclonal Antibody SWOT Analysis
Table 48. Merk Recent Developments
Table 49. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Basic Information
Table 50. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Product Overview
Table 51. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Bristol-Myers Squibb Company Business Overview
Table 53. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody SWOT Analysis
Table 54. Bristol-Myers Squibb Company Recent Developments
Table 55. Roche PD-1 and PD-L1 Monoclonal Antibody Basic Information
Table 56. Roche PD-1 and PD-L1 Monoclonal Antibody Product Overview
Table 57. Roche PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Roche PD-1 and PD-L1 Monoclonal Antibody SWOT Analysis
Table 59. Roche Business Overview
Table 60. Roche Recent Developments
Table 61. Pfizer PD-1 and PD-L1 Monoclonal Antibody Basic Information
Table 62. Pfizer PD-1 and PD-L1 Monoclonal Antibody Product Overview
Table 63. Pfizer PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Pfizer Business Overview
Table 65. Pfizer Recent Developments
Table 66. AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Basic Information
Table 67. AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Product Overview
Table 68. AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. AstraZeneca Business Overview
Table 70. AstraZeneca Recent Developments
Table 71. Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Basic Information
Table 72. Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Product Overview
Table 73. Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Junshi Biosciences Business Overview
Table 75. Junshi Biosciences Recent Developments
Table 76. Innovent PD-1 and PD-L1 Monoclonal Antibody Basic Information
Table 77. Innovent PD-1 and PD-L1 Monoclonal Antibody Product Overview
Table 78. Innovent PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Innovent Business Overview
Table 80. Innovent Recent Developments
Table 81. Hengrui PD-1 and PD-L1 Monoclonal Antibody Basic Information
Table 82. Hengrui PD-1 and PD-L1 Monoclonal Antibody Product Overview
Table 83. Hengrui PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Hengrui Business Overview
Table 85. Hengrui Recent Developments
Table 86. BeiGene PD-1 and PD-L1 Monoclonal Antibody Basic Information
Table 87. BeiGene PD-1 and PD-L1 Monoclonal Antibody Product Overview
Table 88. BeiGene PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. BeiGene Business Overview
Table 90. BeiGene Recent Developments
Table 91. Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Basic Information
Table 92. Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Product Overview
Table 93. Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Alphamab Oncology Business Overview
Table 95. Alphamab Oncology Recent Developments
Table 96. Cstone PD-1 and PD-L1 Monoclonal Antibody Basic Information
Table 97. Cstone PD-1 and PD-L1 Monoclonal Antibody Product Overview
Table 98. Cstone PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Cstone Business Overview
Table 100. Cstone Recent Developments
Table 101. Akeso PD-1 and PD-L1 Monoclonal Antibody Basic Information
Table 102. Akeso PD-1 and PD-L1 Monoclonal Antibody Product Overview
Table 103. Akeso PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Akeso Business Overview
Table 105. Akeso Recent Developments
Table 106. Global PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Region (2025-2030) & (Kilotons)
Table 107. Global PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Country (2025-2030) & (Kilotons)
Table 109. North America PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Country (2025-2030) & (Kilotons)
Table 111. Europe PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Region (2025-2030) & (Kilotons)
Table 113. Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Country (2025-2030) & (Kilotons)
Table 115. South America PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Type (2025-2030) & (Kilotons)
Table 119. Global PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global PD-1 and PD-L1 Monoclonal Antibody Price Forecast by Type (2025-2030) & (USD/Ton)
Table 121. Global PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons) Forecast by Application (2025-2030)
Table 122. Global PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. PD-1 and PD-L1 Monoclonal Antibody Market Size Comparison by Region (M USD)
Table 5. Global PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Manufacturers (2019-2024)
Table 7. Global PD-1 and PD-L1 Monoclonal Antibody Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1 and PD-L1 Monoclonal Antibody as of 2022)
Table 10. Global Market PD-1 and PD-L1 Monoclonal Antibody Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers PD-1 and PD-L1 Monoclonal Antibody Sales Sites and Area Served
Table 12. Manufacturers PD-1 and PD-L1 Monoclonal Antibody Product Type
Table 13. Global PD-1 and PD-L1 Monoclonal Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of PD-1 and PD-L1 Monoclonal Antibody
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. PD-1 and PD-L1 Monoclonal Antibody Market Challenges
Table 22. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Type (Kilotons)
Table 23. Global PD-1 and PD-L1 Monoclonal Antibody Market Size by Type (M USD)
Table 24. Global PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons) by Type (2019-2024)
Table 25. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type (2019-2024)
Table 26. Global PD-1 and PD-L1 Monoclonal Antibody Market Size (M USD) by Type (2019-2024)
Table 27. Global PD-1 and PD-L1 Monoclonal Antibody Market Size Share by Type (2019-2024)
Table 28. Global PD-1 and PD-L1 Monoclonal Antibody Price (USD/Ton) by Type (2019-2024)
Table 29. Global PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons) by Application
Table 30. Global PD-1 and PD-L1 Monoclonal Antibody Market Size by Application
Table 31. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2019-2024) & (Kilotons)
Table 32. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2019-2024)
Table 33. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2019-2024) & (M USD)
Table 34. Global PD-1 and PD-L1 Monoclonal Antibody Market Share by Application (2019-2024)
Table 35. Global PD-1 and PD-L1 Monoclonal Antibody Sales Growth Rate by Application (2019-2024)
Table 36. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2019-2024) & (Kilotons)
Table 37. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region (2019-2024)
Table 38. North America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2019-2024) & (Kilotons)
Table 41. South America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2019-2024) & (Kilotons)
Table 43. Merk PD-1 and PD-L1 Monoclonal Antibody Basic Information
Table 44. Merk PD-1 and PD-L1 Monoclonal Antibody Product Overview
Table 45. Merk PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Merk Business Overview
Table 47. Merk PD-1 and PD-L1 Monoclonal Antibody SWOT Analysis
Table 48. Merk Recent Developments
Table 49. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Basic Information
Table 50. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Product Overview
Table 51. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Bristol-Myers Squibb Company Business Overview
Table 53. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody SWOT Analysis
Table 54. Bristol-Myers Squibb Company Recent Developments
Table 55. Roche PD-1 and PD-L1 Monoclonal Antibody Basic Information
Table 56. Roche PD-1 and PD-L1 Monoclonal Antibody Product Overview
Table 57. Roche PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Roche PD-1 and PD-L1 Monoclonal Antibody SWOT Analysis
Table 59. Roche Business Overview
Table 60. Roche Recent Developments
Table 61. Pfizer PD-1 and PD-L1 Monoclonal Antibody Basic Information
Table 62. Pfizer PD-1 and PD-L1 Monoclonal Antibody Product Overview
Table 63. Pfizer PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Pfizer Business Overview
Table 65. Pfizer Recent Developments
Table 66. AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Basic Information
Table 67. AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Product Overview
Table 68. AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. AstraZeneca Business Overview
Table 70. AstraZeneca Recent Developments
Table 71. Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Basic Information
Table 72. Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Product Overview
Table 73. Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Junshi Biosciences Business Overview
Table 75. Junshi Biosciences Recent Developments
Table 76. Innovent PD-1 and PD-L1 Monoclonal Antibody Basic Information
Table 77. Innovent PD-1 and PD-L1 Monoclonal Antibody Product Overview
Table 78. Innovent PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Innovent Business Overview
Table 80. Innovent Recent Developments
Table 81. Hengrui PD-1 and PD-L1 Monoclonal Antibody Basic Information
Table 82. Hengrui PD-1 and PD-L1 Monoclonal Antibody Product Overview
Table 83. Hengrui PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Hengrui Business Overview
Table 85. Hengrui Recent Developments
Table 86. BeiGene PD-1 and PD-L1 Monoclonal Antibody Basic Information
Table 87. BeiGene PD-1 and PD-L1 Monoclonal Antibody Product Overview
Table 88. BeiGene PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. BeiGene Business Overview
Table 90. BeiGene Recent Developments
Table 91. Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Basic Information
Table 92. Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Product Overview
Table 93. Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Alphamab Oncology Business Overview
Table 95. Alphamab Oncology Recent Developments
Table 96. Cstone PD-1 and PD-L1 Monoclonal Antibody Basic Information
Table 97. Cstone PD-1 and PD-L1 Monoclonal Antibody Product Overview
Table 98. Cstone PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Cstone Business Overview
Table 100. Cstone Recent Developments
Table 101. Akeso PD-1 and PD-L1 Monoclonal Antibody Basic Information
Table 102. Akeso PD-1 and PD-L1 Monoclonal Antibody Product Overview
Table 103. Akeso PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Akeso Business Overview
Table 105. Akeso Recent Developments
Table 106. Global PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Region (2025-2030) & (Kilotons)
Table 107. Global PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Country (2025-2030) & (Kilotons)
Table 109. North America PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Country (2025-2030) & (Kilotons)
Table 111. Europe PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Region (2025-2030) & (Kilotons)
Table 113. Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Country (2025-2030) & (Kilotons)
Table 115. South America PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Type (2025-2030) & (Kilotons)
Table 119. Global PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global PD-1 and PD-L1 Monoclonal Antibody Price Forecast by Type (2025-2030) & (USD/Ton)
Table 121. Global PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons) Forecast by Application (2025-2030)
Table 122. Global PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of PD-1 and PD-L1 Monoclonal Antibody
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global PD-1 and PD-L1 Monoclonal Antibody Market Size (M USD), 2019-2030
Figure 5. Global PD-1 and PD-L1 Monoclonal Antibody Market Size (M USD) (2019-2030)
Figure 6. Global PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. PD-1 and PD-L1 Monoclonal Antibody Market Size by Country (M USD)
Figure 11. PD-1 and PD-L1 Monoclonal Antibody Sales Share by Manufacturers in 2023
Figure 12. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Share by Manufacturers in 2023
Figure 13. PD-1 and PD-L1 Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market PD-1 and PD-L1 Monoclonal Antibody Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by PD-1 and PD-L1 Monoclonal Antibody Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global PD-1 and PD-L1 Monoclonal Antibody Market Share by Type
Figure 18. Sales Market Share of PD-1 and PD-L1 Monoclonal Antibody by Type (2019-2024)
Figure 19. Sales Market Share of PD-1 and PD-L1 Monoclonal Antibody by Type in 2023
Figure 20. Market Size Share of PD-1 and PD-L1 Monoclonal Antibody by Type (2019-2024)
Figure 21. Market Size Market Share of PD-1 and PD-L1 Monoclonal Antibody by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global PD-1 and PD-L1 Monoclonal Antibody Market Share by Application
Figure 24. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2019-2024)
Figure 25. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application in 2023
Figure 26. Global PD-1 and PD-L1 Monoclonal Antibody Market Share by Application (2019-2024)
Figure 27. Global PD-1 and PD-L1 Monoclonal Antibody Market Share by Application in 2023
Figure 28. Global PD-1 and PD-L1 Monoclonal Antibody Sales Growth Rate by Application (2019-2024)
Figure 29. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region (2019-2024)
Figure 30. North America PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country in 2023
Figure 32. U.S. PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico PD-1 and PD-L1 Monoclonal Antibody Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country in 2023
Figure 37. Germany PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region in 2023
Figure 44. China PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (Kilotons)
Figure 50. South America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country in 2023
Figure 51. Brazil PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region in 2023
Figure 56. Saudi Arabia PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global PD-1 and PD-L1 Monoclonal Antibody Market Share Forecast by Type (2025-2030)
Figure 65. Global PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Application (2025-2030)
Figure 66. Global PD-1 and PD-L1 Monoclonal Antibody Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of PD-1 and PD-L1 Monoclonal Antibody
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global PD-1 and PD-L1 Monoclonal Antibody Market Size (M USD), 2019-2030
Figure 5. Global PD-1 and PD-L1 Monoclonal Antibody Market Size (M USD) (2019-2030)
Figure 6. Global PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. PD-1 and PD-L1 Monoclonal Antibody Market Size by Country (M USD)
Figure 11. PD-1 and PD-L1 Monoclonal Antibody Sales Share by Manufacturers in 2023
Figure 12. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Share by Manufacturers in 2023
Figure 13. PD-1 and PD-L1 Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market PD-1 and PD-L1 Monoclonal Antibody Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by PD-1 and PD-L1 Monoclonal Antibody Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global PD-1 and PD-L1 Monoclonal Antibody Market Share by Type
Figure 18. Sales Market Share of PD-1 and PD-L1 Monoclonal Antibody by Type (2019-2024)
Figure 19. Sales Market Share of PD-1 and PD-L1 Monoclonal Antibody by Type in 2023
Figure 20. Market Size Share of PD-1 and PD-L1 Monoclonal Antibody by Type (2019-2024)
Figure 21. Market Size Market Share of PD-1 and PD-L1 Monoclonal Antibody by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global PD-1 and PD-L1 Monoclonal Antibody Market Share by Application
Figure 24. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2019-2024)
Figure 25. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application in 2023
Figure 26. Global PD-1 and PD-L1 Monoclonal Antibody Market Share by Application (2019-2024)
Figure 27. Global PD-1 and PD-L1 Monoclonal Antibody Market Share by Application in 2023
Figure 28. Global PD-1 and PD-L1 Monoclonal Antibody Sales Growth Rate by Application (2019-2024)
Figure 29. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region (2019-2024)
Figure 30. North America PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country in 2023
Figure 32. U.S. PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada PD-1 and PD-L1 Monoclonal Antibody Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico PD-1 and PD-L1 Monoclonal Antibody Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country in 2023
Figure 37. Germany PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region in 2023
Figure 44. China PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (Kilotons)
Figure 50. South America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country in 2023
Figure 51. Brazil PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region in 2023
Figure 56. Saudi Arabia PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa PD-1 and PD-L1 Monoclonal Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global PD-1 and PD-L1 Monoclonal Antibody Market Share Forecast by Type (2025-2030)
Figure 65. Global PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Application (2025-2030)
Figure 66. Global PD-1 and PD-L1 Monoclonal Antibody Market Share Forecast by Application (2025-2030)
